Factor Xa inhibition

被引：2

作者：

Bramlage, P ^{[1
]}

Pittrow, D ^{[1
]}

Kirch, W ^{[1
]}

机构：

[1] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Clin Pharmacol, D-01307 Dresden, Germany

来源：

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2005年 / 35卷

关键词：

factor Xa; fondaparinux; heparin; history; thrombin;

D O I：

10.1111/j.0960-135X.2005.01450.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1 / 3

页数：3

共 9 条

[1] From heparins to factor Xa inhibitors and beyond [J].

Alban, S .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 :12-20

[2] The 'precautionary principle' as a guide for future drug development [J].

Alban, S .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 :33-44

[3] ANTICOAGULANT PROPERTIES OF HEPARIN FRACTIONATED BY AFFINITY CHROMATOGRAPHY ON MATRIX-BOUND ANTITHROMBIN-3 AND BY GEL-FILTRATION [J].

ANDERSSON, LO ;

BARROWCLIFFE, TW ;

HOLMER, E ;

JOHNSON, EA ;

SIMS, GEC .

THROMBOSIS RESEARCH, 1976, 9 (06) :575-583

[4] Fondaparinux: an update on new study results [J].

Bauersachs, RM .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 :27-32

[5] Current concepts for the prevention of venous thromboembolism [J].

Bramlage, P ;

Pittrow, D ;

Kirch, W .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 :4-11

[6] Rationale for the use of antifactor Xa in the treatment and prevention of venous and arterial thromboembolic events [J].

Drouet, L ;

Sollier, CBD .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 :21-26

[7] The potential role of fondaparinux as venous thromboembolism prophylaxis after total hip or knee replacement or hip fracture surgery [J].

Heit, JA .

ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (16) :1806-1808

[8]

OWEN CA, 1990, AM J CLIN PATHOL, V93, pS3

[9]

RATNOFF OD, 1996, DISORDERS HEMOSTASIS, P1

← 1 →